NCT01605370View on ClinicalTrials.gov

Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?

PHASE4TerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Hypertension

Interventions

DRUG

Nebivolol

Nebivolol 2.5 mg once daily

DRUG

Metoprolol succinate

Metoprolol succinate 50 mg once daily

Trial Locations (1)

85259

Mayo Clinic Arizona, Scottsdale

Sponsors

Lead Sponsor

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

Mayo Clinic

OTHER